Lurasidone Hydrochloride
NDC 69097-938, Lurasidone Hydrochloride, tablet, film coated, from Cipla USA, Inc..
- Product NDC
- 69097-938
- Status
- Listed
- Labeler
- Cipla USA, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208028
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-938 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LURASIDONE HYDROCHLORIDE80 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-938-02 | 69097093802 | 30 TABLET, FILM COATED in 1 BOTTLE (69097-938-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/76c055aa-d96a-42e5-a670-1db63b9c1dd6
Use it
Look up 69097-938 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-938 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-938. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.